Chemical Formula: C36H38F4N4O2S

Chemical Formula C36H38F4N4O2S

Found 2 metabolite its formula value is C36H38F4N4O2S

Darapladib

N-[2-(Diethylamino)ethyl]-2-(2-{[(4-fluorophenyl)methyl]sulphanyl}-4-oxo-1H,4H,5H,6H,7H-cyclopenta[D]pyrimidin-1-yl)-N-{[4-(trifluoromethyl)-[1,1-biphenyl]-4-yl]methyl}acetamide

C36H38F4N4O2S (666.2651456)


C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent D004791 - Enzyme Inhibitors > D064801 - Phospholipase A2 Inhibitors Darapladib (SB-480848) is an orally active, selective and reversible Lp-PLA2 inhibitor (IC50=0.25 nM). Darapladib can trigger irreversible actions on glioma cell apoptosis and induce cycle arrest. Darapladib can be used in the study of atherosclerosis and cancer[1][2][3][4].

   

Darapladib

Darapladib

C36H38F4N4O2S (666.2651456)


C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent D004791 - Enzyme Inhibitors > D064801 - Phospholipase A2 Inhibitors Darapladib (SB-480848) is an orally active, selective and reversible Lp-PLA2 inhibitor (IC50=0.25 nM). Darapladib can trigger irreversible actions on glioma cell apoptosis and induce cycle arrest. Darapladib can be used in the study of atherosclerosis and cancer[1][2][3][4].